SCHEMBL16020173

SCHEMBL16020173

CC(C)[Si](C(C)C)(C(C)C)n1cc(Br)c2ccc(S(=O)(=S)Cl)nc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14699127 0.91 — —
SCHEMBL14698731 0.69 HTR6 (0.31) —
SCHEMBL414164 0.67 ELANE (0.42) —
SCHEMBL15025087 0.65 PDGFRA (0.35) —
SCHEMBL18233837 0.60 HTR2C (0.33) —
SCHEMBL12127680 0.60 L3MBTL1 (0.37) —
SCHEMBL1077028 0.59 HTR6 (0.35) —
SCHEMBL12234516 0.57 — —
SCHEMBL4079517 0.57 ADK (0.44) —
SCHEMBL517770 0.57 HTR6 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9079902-B2 Heteroaryl sodium channel inhibitors AMGEN INC. (US) 2015-07-14 — — US disclosed
US-20140256707-A1 Heteroaryl Sodium Channel Inhibitors AMGEN INC. (US) 2014-09-11 — — US disclosed
Send feedback